The discovery of immunoglobulin E (IgE) as a key player in allergic diseases, and the association of higher mean plasma levels of IgE with severe asthma [11], provided the rationale for developing safe and effective targeted anti-IgE therapy. This evidence concerns the gene IGHE and asthma.